OKYO Pharma Limited (OKYO)
NASDAQ: OKYO
· Real-Time Price · USD
2.63
-0.01 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
2.60
-1.29%
After-hours: Aug 15, 2025, 07:46 PM EDT
OKYO Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2025 | Q1 2025 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | -1.34K | -1.34K | n/a | -4.41K | -3.82K | -3.89K | -5.53M | -2.28K | -2.88M | -1.09K | -2.55M | -917.73 | -2.8M | -1.04K | -1.17M | -243.01 |
Depreciation & Amortization | 1.27K | 0.60 | n/a | 1.04 | 1.05 | 1.07 | 1.66K | 0.68 | -5.07 | -5.1 | 16.54K | 5.96 | 10.12K | 3.64 | 3.19K | 1.37 |
Stock-Based Compensation | 302.27 | 302.27 | n/a | 295.34 | 348.09 | 357.27 | 318.16 | 284.91 | 363.10 | 343.30 | 321.66 | 321.66 | 209.60 | 211.95 | 18.95 | 18.95 |
Other Working Capital | 43.46 | 43.46 | n/a | -50.61 | 36.45 | 37.69 | 1.05M | 38.32 | 834.9K | -281.38 | -1.08M | -15.19 | 1.18M | n/a | -316.42K | n/a |
Other Non-Cash Items | -298 | 975.11 | n/a | 568.13 | 1.45K | 1.46K | 682.01K | 446.45 | 1.08M | 87.25 | 780.68K | -480.1 | 459.29K | 412.78 | 554.45K | -67.93 |
Deferred Income Tax | n/a | n/a | n/a | n/a | -0.00 | -0.00 | 131.24K | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -58.73 | -58.73 | n/a | 147.77 | -32.31 | -29.28 | 1.19M | 93.90 | 150.8K | -268.5 | -1.16M | -17.94 | 1.2M | 2.10 | -122.62K | 76.27 |
Operating Cash Flow | -120 | -120.67 | n/a | -3.4K | -2.05K | -2.1K | -3.52M | -1.45K | -2.33M | -932.19 | -3.02M | -1.09K | -1.13M | -408.14 | -542.9K | -214.35 |
Capital Expenditures | n/a | n/a | n/a | n/a | -1.46 | -1.5 | -2.94K | -1.21 | -1.71K | -0.62 | n/a | n/a | -4.89K | -1.77 | -1.9K | -0.75 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.52K | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | -3.84 | -4.27 | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | -1.46 | -1.5 | -2.94K | -1.21 | -1.71K | -0.62 | n/a | n/a | -16.4K | -6.04 | -1.9K | -0.75 |
Debt Repayment | 550K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.48 | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 551.81K | 275.90 | n/a | 2K | 3.74K | 3.77K | -2.43M | 903.30 | 15.02K | 376.24 | -1.45M | 715.50 | 7.98M | 29.15 | -71.52K | 3K |
Financial Cash Flow | 551.81K | 275.90 | n/a | 2K | 3.74K | 3.77K | 1.8M | 742.07 | -30.49K | 278.22 | 1.44M | 517.25 | 570.83K | 29.15 | 7.6M | 3K |
Net Cash Flow | n/a | n/a | n/a | -4.05K | n/a | 1.53K | -2M | -710.94 | -2.48M | -977.05 | -1.7M | -570.89 | -561.75K | -385.02 | 7.21M | 2.79K |
Free Cash Flow | -120 | -120.67 | n/a | -3.4K | -2.05K | -2.1K | -3.53M | -1.45K | -2.33M | -932.81 | -3.02M | -1.09K | -1.14M | -409.9 | -544.8K | -215.1 |